InnoVactiv, Idealfarma Promote InSea2 in Brazil
InnoVactiv (Rimouski, QC, Canada) has partnered with Idealfarma (Anapolis, Brazil) to promote InnoVactiv’s InSea2 ingredient in Brazil.
InnoVactiv (Rimouski, QC, Canada) has partnered with Idealfarma (Anapolis, Brazil) to promote InnoVactiv’s InSea2 ingredient in Brazil.
InSea2 is the only product on the market today to exhibit a dual mechanism of action against digestive enzymes involved in carbohydrate digestion and assimilation, according to the companies. It is a 100% natural ingredient derived from brown seaweed. Notably, the ingredient helps diminish the hyperglycemic peak that occurs following a high-glycemic-index meal.
Brazil represents the 10th largest national economy. “This collaboration will help us significantly increase the notoriety of our ingredient InSea2 at the international level,” says Patrice Dionne, InnoVactiv’s CEO.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
